Reports of hypersensitivity reactions, including anaphylaxis (a life-threatening allergic reaction), angioedema, low blood pressure, rapid heart rate, swollen tongue, difficulty breathing, wheezing, or rash.
Entries Tagged as 'FDA Alerts'
Saphris (asenapine maleate): Drug Safety Communication: Serious Allergic Reactions
September 1st, 2011 · No Comments
Tags: FDA · FDA Alerts
Reclast (zoledronic acid): Drug Safety Communication - New Contraindication and Updated Warning on Kidney Impairment
September 1st, 2011 · No Comments
Reclast should not be used in patients with creatinine clearance less than 35 mL/min or in patients with evidence of acute renal impairment.
Tags: FDA · FDA Alerts
H & P Industries Povidone Iodine Swabsticks, Prep Solutions, Scrub Solutions, and Prep Gel: Recall - Inadequate Microbial Testing
August 26th, 2011 · No Comments
High risk of infection from antiseptic surgical preparations that have been prepared, packaged, or held under insanitary conditions.
Tags: FDA · FDA Alerts
ShoulderFlex Massager by King International: Safety Communication - Risk of Strangulation
August 26th, 2011 · No Comments
Hair, clothing, and jewelry can become entangled in the massage device and cause serious injury or death.
Tags: FDA · FDA Alerts
Celexa (citalopram hydrobromide): Drug Safety Communication - Abnormal Heart Rhythms Associated With High Doses
August 24th, 2011 · No Comments
Citalopram should no longer be prescribed at doses greater than 40 mg per day.
Tags: FDA · FDA Alerts